Ictero Medical is a pioneering brand that offers a groundbreaking solution for gallstone disease. With a focus on providing patients with the benefits of surgery without the associated risks, Ictero has developed the innovative CholeSafe System. This minimally invasive gallbladder ablation solution effectively freezes gallstone disease in its tracks.

What sets Ictero apart is its team of industry, clinical, and business experts who are dedicated to addressing today's pressing clinical needs. Born out of the esteemed Texas Medical Center Biodesign fellowship, this passionate team of engineers, scientists, clinicians, and entrepreneurs have meticulously crafted a commercially viable, definitive, and safe treatment for gallstone disease. The driving force behind Ictero Medical includes Matthew Nojoomi, the CEO and Co-Founder, David Waters, the COO and Co-Founder, Kovi Bessoff, the Clinical Research Lead and Co-Founder, and Raymond Kirk, the CMO.

With the support of their collaborating partners, Ictero Medical is poised to revolutionize the field of gallstone disease treatment